Tarinee Manchana

ORCID: 0000-0001-7088-628X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Pelvic floor disorders treatments
  • Cervical Cancer and HPV Research
  • BRCA gene mutations in cancer
  • Anorectal Disease Treatments and Outcomes
  • Urinary Tract Infections Management
  • Genetic factors in colorectal cancer
  • Urinary Bladder and Prostate Research
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Cancer Genomics and Diagnostics
  • Hemoglobinopathies and Related Disorders
  • Erythropoietin and Anemia Treatment
  • Palliative Care and End-of-Life Issues
  • RNA Research and Splicing
  • Patient Dignity and Privacy
  • PARP inhibition in cancer therapy
  • Management of metastatic bone disease
  • Nausea and vomiting management
  • Neuroblastoma Research and Treatments
  • Minimally Invasive Surgical Techniques
  • Diverticular Disease and Complications
  • Pelvic and Acetabular Injuries
  • Gastric Cancer Management and Outcomes

Chulalongkorn University
2014-2025

King Chulalongkorn Memorial Hospital
2004-2024

Bangkok Hospital
2004

Objective The objective of the ConCerv Trial was to prospectively evaluate feasibility conservative surgery in women with early-stage, low-risk cervical cancer. Methods From April 2010 March 2019, a prospective, single-arm, multicenter study evaluated participants from 16 sites nine countries. Eligibility criteria included: (1) FIGO 2009 stage IA2–IB1 carcinoma; (2) squamous cell (any grade) or adenocarcinoma (grade 1 2 only) histology; (3) tumor size < cm; (4) no lymphovascular space...

10.1136/ijgc-2021-002921 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2021-09-07

10.1007/s00404-010-1675-y article EN Archives of Gynecology and Obstetrics 2010-09-16

Objective This study aimed to compare clinicopathological characteristics and oncological outcomes in patients with endometrial cancer aged ≤45 >45 years, a focus on identifying distinct traits prognostic factors younger patients. Design A retrospective cohort study. Setting The was conducted at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, restricted population from 1996 2016. Participants total of 1114 diagnosed underwent surgery were strictly selected, excluding those who...

10.1136/bmjopen-2024-089434 article EN cc-by-nc-nd BMJ Open 2025-01-01

10.1007/s00404-023-07299-9 article EN Archives of Gynecology and Obstetrics 2024-01-08

Purpose: To compare perioperative outcomes and oncologic in endometrial cancer patients treated with laparotomy, laparoscopic or robotic surgery. Materials Methods: Endometrial who underwent primary surgery from January 2011 to December 2014 were retrospectively reviewed. Perioperative outcomes, including estimated blood loss (EBL), operation time, number of lymph nodes retrieved, intra postoperative complications, Recovery disease free survival (DFS) overall (OS) compared. Results: Of the...

10.7314/apjcp.2015.16.13.5483 article EN cc-by Asian Pacific Journal of Cancer Prevention 2015-08-03

Preoperative evaluations aiming to assess high-risk features in clinical stage 1 endometrial cancer patients are crucial refer these gynecologic oncologists. Cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) have been reported with poor prognostic factors.To evaluate the association between preoperative levels of CA125 HE4 establish optimal cut-off values cancer.A retrospective study was conducted who underwent primary surgery January 2013 December 2018. A total 128 had serum...

10.5306/wjco.v11.i6.378 article EN World Journal of Clinical Oncology 2020-06-24

The purpose of this study was to evaluate the incidence pelvic/para-aortic node metastases and other pathological characteristics from medical records patients with endometrial carcinoma treated at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, between1996 2005. 213 who had complete surgical staging were reviewed. A particular focus on clinically early-stage disease. Clinical could be determined in 206 patients. Of patients, 182 (88.3%) presented clinical stage I However, only 142...

10.1111/igc.0b013e3181a8ba85 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2009-07-01

Bethanechol chloride is considered as a treatment in patients with high postvoid residual urine (PVR). It enhances detrusor muscle contraction, resulting higher maximum flow rate, pressure at flow, and lower PVR. The efficacy of this agent after radical hysterectomy unclear. We aim to evaluate the bethanechol compared placebo for prevention bladder dysfunction type III hysterectomy.Gynecologic cancer who underwent were randomized by computer-generated schedule assign 1:1 ratio into 2 groups....

10.1111/igc.0b013e3181f7d6de article EN PubMed 2011-05-01

Pyomyoma (suppurative leiomyoma) is a rare disease, which considered to be serious complication of uterine leiomyoma. Since 1945, only 18 patients have been reported and ours the 19th. Although it frequently in pregnant women or postmenopausal who vascular our case 42-year-old woman perimenopausal period presented with fever tender lower abdominal mass. She used intrauterine device as contraceptive method but leiomyoma had never found before. Ultrasonographic findings suggested an ovarian...

10.1159/000097370 article EN Gynecologic and Obstetric Investigation 2006-11-23

Hysterectomy is the most frequent gynaecological procedure carried out with either conventional (abdominal) or minimally invasive surgery (MIS). Despite advantage of MIS compared procedure, it requires extensive training and a long learning curve. Minilaparotomy hysterectomy an alternative approach that needs no sophisticated expensive equipment training. The objective this study was to compare perioperative outcomes between minilaparotomy (MH) laparoscopic (LH) in patients benign diseases....

10.3109/01443615.2013.828685 article EN Journal of Obstetrics and Gynaecology 2013-12-20
Coming Soon ...